Clinical Trials · NCT02205528
A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 108
- Start date
- Aug 2014
- Locations
- 20 sites, United States
- Primary endpoint
- Change in HbA1c